Form 10-Q - Quarterly report [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Veru (NASDAQ:VERU)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Veru Charts.

Veru (NASDAQ:VERU)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Veru Charts.

Veru Inc News

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
Wednesday 15 May 2024 (2 days ago) • GlobeNewswire Inc.

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
Tuesday 14 May 2024 (3 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 May 2024 (1 week ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 9 May 2024 (1 week ago) • Edgar (US Regulatory)

Form DEFR14A - Revised definitive proxy soliciting materials
Thursday 9 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 May 2024 (1 week ago) • Edgar (US Regulatory)

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
Wednesday 8 May 2024 (1 week ago) • GlobeNewswire Inc.

Veru to Present at the GLP-1 Based Therapeutics Summit
Thursday 2 May 2024 (2 weeks ago) • GlobeNewswire Inc.

More Veru Inc News Articles

Synthetix Network Token

Vontobel Financial Produ...

Leonteq Securities

Strategic Technology & E...

Erilia SA 1.5% 3mar2034

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions